nimodipine has been researched along with Deafness, Transitory in 4 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scheller, C | 1 |
Wienke, A | 1 |
Tatagiba, M | 1 |
Gharabaghi, A | 1 |
Ramina, KF | 1 |
Ganslandt, O | 1 |
Bischoff, B | 1 |
Zenk, J | 1 |
Engelhorn, T | 1 |
Matthies, C | 1 |
Westermaier, T | 1 |
Antoniadis, G | 1 |
Pedro, MT | 1 |
Rohde, V | 1 |
von Eckardstein, K | 1 |
Kretschmer, T | 1 |
Kornhuber, M | 1 |
Steighardt, J | 1 |
Richter, M | 1 |
Barker, FG | 1 |
Strauss, C | 1 |
Youssef, AS | 1 |
Downes, AE | 1 |
Kleffner, I | 1 |
Ringelstein, EB | 1 |
Stupp, N | 1 |
Niederstadt, TU | 1 |
Young, P | 1 |
Woolridge, D | 1 |
Stefanelli, M | 1 |
Hoppe, B | 1 |
1 review available for nimodipine and Deafness, Transitory
Article | Year |
---|---|
Intraoperative neurophysiological monitoring in vestibular schwannoma surgery: advances and clinical implications.
Topics: Action Potentials; Cochlear Nerve; Electromyography; Evoked Potentials, Auditory, Brain Stem; Facial | 2009 |
1 trial available for nimodipine and Deafness, Transitory
Article | Year |
---|---|
Prophylactic nimodipine treatment and improvement in hearing outcome after vestibular schwannoma surgery: a combined analysis of a randomized, multicenter, Phase III trial and its pilot study.
Topics: Adult; Female; Hearing; Hearing Loss; Hearing Tests; Humans; Male; Middle Aged; Neuroma, Acoustic; N | 2017 |
2 other studies available for nimodipine and Deafness, Transitory
Article | Year |
---|---|
Neurological picture. Susac's syndrome: effective combination of immunosuppression and antiplatelet treatment.
Topics: Adolescent; Aspirin; Brain Diseases; Corpus Callosum; Female; Glucocorticoids; Hearing Loss; Humans; | 2006 |
Susac syndrome with frontal intermittent rhythmic delta activity (FIRDA).
Topics: Adult; Brain Diseases; Calcium Channel Blockers; Delta Rhythm; Gait Disorders, Neurologic; Hearing L | 2006 |